ACM
LLY icon

Arlington Capital Management’s Eli Lilly LLY Stock Holding History

Arlington Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-320
Closed -$244K – 111
2025
Q3 		$244K Buy
+320
New +$238K 0.16% 86

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arlington Capital Management's LLY Position: Q4 2025 in Review

Arlington Capital Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 320 shares — an estimated $244K sold.

Arlington Capital Management first reported a position in LLY in Q3 2025 and held it in 1 quarter. The position peaked at $244K in Q3 2025. 4,432 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Arlington Capital Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Arlington Capital Management sold 320 Eli Lilly shares in Q4 2025, an estimated $244K.
  • Arlington Capital Management first reported a position in Eli Lilly in Q3 2025 and held it in 1 quarter.
  • Arlington Capital Management's Eli Lilly position peaked at $244K in Q3 2025.
  • 4,432 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Arlington Capital Management's 13F filing for Q4 2025, filed 6 Jan 2026.